MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia
Muhammad Erfan Uddin(The Ohio State University), Alex Sparreboom(The Ohio State University)
Cited by 10
Related Papers
Cremophor EL
|European Journal of Cancer|2001|1.6k
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
|PubMed|2001|752
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors
|Cancer Biology & Therapy|2006|155
Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2‐methoxyestradiol
|Journal of Pharmaceutical Sciences|2007|38